NGENLA 60mg (Somatrogon-Ghla PFS) 60 mg/1.2 mL (50 mg/mL)

NGENLA 60mg is a somatrogon-ghla injection in a prefilled syringe, used for growth hormone therapy. Store between 2-8°C to maintain potency. Ideal for patients requiring growth hormone treatment. Suitable for those managing growth disorders.

Strength

60 mg/1.2 mL (50 mg/mL)

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NGENLA 60mg is used to treat growth hormone deficiency in children and adults. It supports normal growth and development in pediatric patients with insufficient natural growth hormone. Adults with growth hormone deficiency may also benefit from this therapy. Commonly prescribed for growth disorders and related conditions.

Side Effects

Users may experience improved growth patterns and better overall development over time. The injection helps maintain consistent hormone levels in the body. Some may notice gradual changes in energy levels and physical growth. Effects vary based on individual response and treatment duration.

Precautions & Warnings

Keep NGENLA 60mg refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the prefilled syringe. Always inspect the solution for particles or discoloration before use. Discard any unused medication properly as directed by healthcare guidelines.

Avoid Interactions

Certain medications, such as corticosteroids or thyroid hormones, may interact with NGENLA 60mg. Alcohol and tobacco use can also affect treatment outcomes. Always inform your healthcare provider about all medications and supplements you are taking. Monitor for any unusual reactions during therapy.

Frequently Asked Questions

NGENLA 60mg is used to treat growth hormone deficiency in children and adults.

Store NGENLA 60mg between 2-8°C and protect it from light.

NGENLA 60mg may be available for purchase through licensed pharmacies or healthcare providers.

Users may experience improved growth patterns and better overall development over time.

Yes, NGENLA 60mg is a prescription medication and should be used under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.